Li Liu

The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease

By redefining the trajectory from preclinical to clinical obesity as an immunometabolic continuum and providing actionable strategies to dismantle this bridge before end-organ damage, this framework offers a paradigm shift in the primary prevention of obesity-related cardiovascular disease.